Moreover, whether immunosuppression therapy plays a role in the development of AKI cannot be proven in this study because CNI was used universally in every case and an mTOR inhibitor was prescribed when AKI occurred or in case of advanced HCC. The gene discussed is MTOR; the disease is hepatocellular carcinoma.